share_log
Reuters ·  May 9 07:11
Mineralys Therapeutics Inc - Current Cash, Cash Equivalents and Investments Will Be Sufficient to Fund Its Planned Clinical Studies Into 2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment